Klinikum Leverkusen

Leverkusen 51375

0 studies enrolling now · 2 studies all time

What they study most

Diffuse Large B-cell Lymphoma, Secondary Acute Myeloid Leukemia (Secondary AML, sAML)

Studies at this site

• Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) — Running, not enrolling
• Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study — Status unconfirmed